Ambrosha Jordan
Family · Charlotte, NCNPI 1700027307
Payments from drug & device makers
Across 311 payments — averaging $25.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Novo Nordisk$1K
- Amgen$866
- AbbVie$701
- Paratek Pharmaceuticals, Inc.$585
- Pfizer$576
- plus $3K from 24 others
What the payments were for
- Food & beverage$7,934100%
- Education$20%
- Gifts$00%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 41 | $1,294 |
| Novo Nordisk | 24 | $1,096 |
| Amgen(2 entities) | 34 | $866 |
| AbbVie | 33 | $701 |
| Paratek Pharmaceuticals, Inc. | 22 | $585 |
| Pfizer | 27 | $576 |
| Lilly USA, LLC | 24 | $526 |
| Astellas Pharma Global Development | 4 | $327 |
| Scilex Pharmaceuticals Inc. | 20 | $302 |
| Otsuka America Pharmaceutical, Inc. | 17 | $295 |
| Bayer | 9 | $219 |
| Astellas Pharma US Inc | 10 | $206 |
| Esperion Therapeutics, Inc. | 5 | $197 |
| Collegium Pharmaceutical, Inc. | 7 | $140 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $90 |
| Sanofi-aventis U.S. LLC | 4 | $76 |
| Exact Sciences | 4 | $76 |
| Boehringer Ingelheim | 3 | $68 |
| Organon | 3 | $48 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $41 |
| Biohaven Pharmaceuticals, Inc. | 2 | $37 |
| Biodelivery Sciences International, Inc. | 2 | $35 |
| Bioventus LLC | 1 | $21 |
| Ardelyx, Inc. | 1 | $20 |
| Baxter Healthcare | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
| Alk-abello, Inc | 1 | $15 |
| Abbott | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,935 in reported general payments places this provider in the 95th percentile of 4,522 family providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 87 | $102,120 |
| MounjaroTirzepatide | 37 | $41,343 |
| JardianceEmpagliflozin | 49 | $40,283 |
| LinzessLinaclotide | 39 | $29,979 |
| FarxigaDapagliflozin Propanediol | 40 | $27,443 |
| Xtampza ErOxycodone Myristate | 39 | $24,611 |
| XareltoRivaroxaban | 31 | $23,972 |
| ZtlidoLidocaine | 18 | $20,190 |
| VraylarCariprazine Hcl | 11 | $15,370 |
| Humalog Kwikpen U-200Insulin Lispro | 13 | $13,577 |
| RybelsusSemaglutide | 13 | $12,630 |
| Spiriva HandihalerTiotropium Bromide | 15 | $11,853 |
| JanuviaSitagliptin Phosphate | 14 | $11,356 |
| Bydureon BciseExenatide Microspheres | 13 | $9,833 |
| DapagliflozinDapagliflozin Propanediol | 11 | $9,379 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,096 | $114,750100 claims |
| AbbVieLinzess, Vraylar, Restasis Multidose | $701 | $53,79463 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $1,294 | $43,48684 claims |
| Lilly USA, LLCMounjaro | $526 | $41,34337 claims |
| Boehringer IngelheimJardiance | $68 | $40,28349 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $140 | $24,61139 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $302 | $20,19018 claims |
| Astellas Pharma US IncVeozah | $206 | $7,22413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,522 family providers in North Carolina.
Other family in Charlotte
- Debra ScottCharlotte$129K
- Lasherri LeathersCharlotte$89K
- Catherine ShahCharlotte$72K
- Jason HardinCharlotte$37K
- Laura ListonCharlotte$33K
- Marie KristensenCharlotte$30K
- Hadley DebergCharlotte$16K
- Morgan HubeliCharlotte$15K
- Trisha WootenCharlotte$15K
- Samantha GriffinCharlotte$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.